Skip to main content

Risk Factors for Venous Thromboembolism: Recognizing the Spectrum of Risk and Understanding the Role of Thrombophilia Testing

  • Chapter
Handbook for Venous Thromboembolism

Abstract

Risk factors for venous thromboembolism (VTE) include inherited thrombophilias, lifestyle-related risk factors, and acquired conditions of endothelial injury, stasis, and hypercoagulability. The majority of VTE patients presents with a combination of multiple risk factors that result in venous thrombosis. Common acquired risk factors include advanced age, malignancy, immobility, inflammation, and recent trauma, surgery, and hospitalization. Thrombophilia testing is most helpful when the results will assist in decision-making for prevention or treatment of VTE.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Piazza G. Thrombophilia testing, recurrent thrombosis, and women’s health. Circulation. 2014;130:283–7.

    Article  PubMed  Google Scholar 

  2. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA. 2005;293:2352–61.

    Article  CAS  PubMed  Google Scholar 

  3. Lijfering WM, Middeldorp S, Veeger NJ, et al. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation. 2010;121:1706–12.

    Article  CAS  PubMed  Google Scholar 

  4. Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997;277:642–5.

    Article  CAS  PubMed  Google Scholar 

  5. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117:93–102.

    Article  PubMed  Google Scholar 

  6. Steffen LM, Folsom AR, Cushman M, Jacobs Jr DR, Rosamond WD. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation. 2007;115:188–95.

    Article  CAS  PubMed  Google Scholar 

  7. Rosengren A, Freden M, Hansson PO, Wilhelmsen L, Wedel H, Eriksson H. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost. 2008;6:558–64.

    Article  CAS  PubMed  Google Scholar 

  8. Piazza G, Goldhaber SZ. Venous thromboembolism and atherothrombosis. Circulation. 2010;121:2146–50.

    Article  PubMed  Google Scholar 

  9. Piazza G, Goldhaber SZ, Lessard DM, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in patients with symptomatic atherosclerosis. Thromb Haemost. 2011;106:1095–102.

    Article  CAS  PubMed  Google Scholar 

  10. Rogers MA, Levine DA, Blumberg N, Flanders SA, Chopra V, Langa KM. Triggers of hospitalization for venous thromboembolism. Circulation. 2012;125:2092–9.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Piazza G. Beyond Virchow’s Triad: does cardiovascular inflammation explain the recurrent nature of venous thromboembolism? Vasc Med. 2015;20:102–4.

    Article  PubMed  Google Scholar 

  12. Folsom AR, Lutsey PL, Astor BC, Cushman M. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. Thromb Haemost. 2009;102:615–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  13. Zee RY, Glynn RJ, Cheng S, Steiner L, Rose L, Ridker PM. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: the Women’s Genome Health Study. Circ Cardiovasc Genet. 2009;2:57–62.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Savchenko AS, Martinod K, Seidman MA, et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost. 2014;12:860–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Glynn RJ, Danielson E, Fonseca FA, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009;360:1851–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Piazza G, Goldhaber SZ, Lessard DM, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. Am J Med. 2011;124:252–9.

    Article  PubMed  Google Scholar 

  17. Piazza G, Seddighzadeh A, Goldhaber SZ. Heart failure in patients with deep vein thrombosis. Am J Cardiol. 2008;101:1056–9.

    Article  PubMed  Google Scholar 

  18. Piazza G, Goldhaber SZ, Kroll A, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in patients with chronic obstructive pulmonary disease. Am J Med. 2012;125:1010–8.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Piazza, G., Hohlfelder, B., Goldhaber, S.Z. (2015). Risk Factors for Venous Thromboembolism: Recognizing the Spectrum of Risk and Understanding the Role of Thrombophilia Testing. In: Handbook for Venous Thromboembolism. Springer, Cham. https://doi.org/10.1007/978-3-319-20843-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20843-5_2

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-20842-8

  • Online ISBN: 978-3-319-20843-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics